Risk management in cardiac anesthesia: analysis of critical issues. Introduction.
Ellison
N
N
University of Pennsylvania, Philadelphia, USA.
Pierce
E C
EC
D000768:Anesthesia, General; D000925:Anticoagulants / Q000627:therapeutic use; D001921:Brain / Q000502:physiology; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D002407:Catheterization, Swan-Ganz; D006493:Heparin / Q000627:therapeutic use; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation; D016343:Monitoring, Intraoperative; D017063:Outcome Assessment, Health Care; D011479:Protamines / Q000627:therapeutic use; D012308:Risk Management; D012449:Safety; D013116:Spinal Cord / Q000502:physiology
D000925:Anticoagulants; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin